Simon Thompson 

Cambridge Cognition aiming to accelerate sales growth

Simon Thompson

Simon Thompson

At the end of last year I covered in quite some detail the pre-close trading update from Aim-traded Cambridge Cognition (COG:77p), a company that has developed a suite of computer-based cognitive assessments to improve the understanding, diagnosis and treatment of neurological and psychological diseases when I rated the shares a hold at 75p (Cambridge Cognition sales shortfall’, 12 Dec 2018).

To continue reading, subscribe today

and enjoy unlimited access to the following:

  • Tips of the Week
  • Funds coverage
  • Weekly features on big investment themes
  • Trading ideas
  • Comprehensive companies coverage
  • Economic analysis
Subscribe
Subscribe to Investors Chronicle

Subscribe today

Full access for just £3.37 a week:

• Tips and recommendations - to beat the market 
• Portfolio clinic & Mr Bearbull - build a well-planned portfolio 
• Expert tools - track and manage investments effortlessly
• Plus free delivery to your home or office

Subscribe Now